Structural Biology

Media release: Novel drug in development to inhibit acute inflammation

Teams led by Bio21's Prof Michael Parker and Prof Karlheinz Peter, Baker in the new Department of Cardiometabolic Health are developing a new anti-inflammatory drug.

Media Release: A step closer to treating common female infection

Bio21's Michael Parker is part of an international collaboration that has shown how the bacteria Gardnerella vaginalis targets cells and causes infection in women

Subscribe to RSS - Structural Biology